SUBSCRIBE
SUBSCRIBE
Lone Star Bio

Emerging Healthcare Solutions, Inc.: Celulas Genetica Eyes China for Testing New Stem Cell Procedure

December 6, 2010 | 
1 min read
HOUSTON--(BUSINESS WIRE)--Emerging Healthcare Solutions, Inc. (PinkSheets:EHSI) announced today that its newly acquired biotechnology division Celulas Genetica seeks to contract a Chinese firm to test a new stem-cell treatment for liver disease.
Asia
MORE ON THIS TOPIC
Creative sketch collage of business people handshake gesture approval project development success colleagues cooperation support.
Collaboration
Alphabet Subsidiary Calico Colors In Up To $570M+ Aging Deal With China’s Mabwell
June 27, 2025
 · 
2 min read
 · 
Tristan Manalac
A pill with the Amercan and Chinese flag wrapped around it
Government
FDA Freezes Trials Shipping Cells to China, ‘Other Hostile Countries’
June 20, 2025
 · 
2 min read
 · 
Tristan Manalac
Business concept illustration of a businessman digging and mining to find treasure
Antibody-drug conjugate (ADC)
NextCure Joins China-ADC Gold Rush with $745M Simcere Deal
June 16, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Halftone hands reaching for money. Mixed media catch falling coins and cash bills collage, financial success, free wealth and easy money concept vector illustration
Autoimmune disease
Cullinan Bets $700M+ in Back-Heavy China Deal for Autoimmune T Cell Engager
June 5, 2025
 · 
2 min read
 · 
Tristan Manalac